Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goupil

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Seminars in Oncology|October 1, 1996
Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I studyC Lhommé, P Kerbrat, C Lejeune, et al.
Bone Reports|January 11, 2020
FGF21, not GCN2, influences bone morphology due to dietary protein restrictionsMargaret A McNulty, Brad A Goupil, Diana C Albarado, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of anthracyclines in the treatment of advanced ovarian cancerH J Lück, A Du Bois, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.
Gynecologic Oncology|September 14, 2000
High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)F Joly, J F Héron, P Kerbrat, et al.
Plos Neglected Tropical Diseases|April 9, 2020
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Lindsey S Garver, et al.
European Journal of Gynaecological Oncology|August 15, 2001
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of CancerH C Wagenaar, S Pecorelli, I Vergote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Seminars in Oncology|October 1, 1996
Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I studyC Lhommé, P Kerbrat, C Lejeune, et al.
Bone Reports|January 11, 2020
FGF21, not GCN2, influences bone morphology due to dietary protein restrictionsMargaret A McNulty, Brad A Goupil, Diana C Albarado, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of anthracyclines in the treatment of advanced ovarian cancerH J Lück, A Du Bois, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.
Gynecologic Oncology|September 14, 2000
High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)F Joly, J F Héron, P Kerbrat, et al.
Plos Neglected Tropical Diseases|April 9, 2020
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Lindsey S Garver, et al.
European Journal of Gynaecological Oncology|August 15, 2001
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of CancerH C Wagenaar, S Pecorelli, I Vergote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 6